Table 1.
Authors | Year | Center | Grading of steatosis (%) | Number of patients | Overall Complication (%) | P value | Mortality (%) | P value |
Behrns et al (35) | 1998 | Mayo Clinic. Rochester, USA. | None | 72 | 10 | NA | 3 | NA |
Mild (<30) | 56 | 14 | 7 | |||||
Marked (≥ 30) | 7 | 29 | 14 | |||||
Belghiti et al (5) | 2000 | Hopital Beaujon. Paris, France. | None | 441 | 8 | 0.003 | 1 | 0.5 |
Steatosis (≥ 30) | 37 | 22 | 0 | |||||
Jamargin et al (6) | 2002 | MSKCC. New York, USA. | None | 1275 | 48 | 0.197 | 3.9 | 0.309 |
Steatosis (≥ 30) | 380 | 44 | 2.8 | |||||
Kooby et al * (36) | 2003 | MSKCC. New York, USA. | None | 160 | 35 | <0.01 | 3.1 | 0.29 |
Mild (<30) | 223 | 48 | 3.6 | |||||
Marked (≥ 30) | 102 | 62 | 5.9 | |||||
Mc Cormack et al * (12) | 2007 | Swiss HPB Center. Zurich, Switzerland. | None | 58 @ | 6.9# | 0.001 | 1.7 | 0.21 |
Steatosis (≥ 10) | 58 @ | 27# | 8.6 |
NA: Not Available; * Case matched analysis; # Referred only to major complication rate using Dindo et al classification (10); @ Only major liver resection were analyzed (≥ 3 liver segments)